Olaris to Present Results from Three Studies Showcasing Non-Invasive Urine Assays for Graft Injury Detection and Drug Compliance at 2025 World Transplant Congress
Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its...
Read disclosure →